• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tevogen Inc. - Common Stock (NQ:TVGN)

6.810 +0.370 (+5.75%)
Delayed Quote Updated: 3:47 PM EDT, Oct 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 35,949
Open 6.580
Bid (Size) 5.870 (200)
Ask (Size) 7.570 (900)
Prev. Close 6.440
Today's Range 6.580 - 7.150
52wk Range 3.636 - 34.99
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
UPDATE – Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC
October 08, 2026
From Tevogen Inc.
Via GlobeNewswire
News headline image
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of HRK Healthcare LLC
October 08, 2026
From Tevogen Inc.
Via GlobeNewswire

Performance

52-Week Range 80.5% below 52-week high
6.810
3.6452W Low 34.9952W High
1 Week 4.1% below 1-week high
6.381W Low 7.101W High

Tevogen Inc. - Common Stock (TVGN) traded between $3.64 and $34.99 over the past 52 weeks and last traded at $6.81, 80.5% below its 52-week high. Over the past week it ranged between $6.38 and $7.10.

Past 12 Months
-3.8%
-8.3%
+60.6%
-16.3%
-62.6%
-79.8%
1W -$0.27
1M -$0.62
3M +$2.57
6M -$1.33
YTD -$11.38
1Y -$26.89

TVGN was -79.8% over the past year, -16.3% over six months, -62.6% year to date, -3.8% in the last week.

12 Months vs Market
TVGN
-79.8%
DIA
+12.5%
SPY
+13.8%
QQQ
+15.2%
IWM
+12.0%

Over the past 12 months TVGN returned -79.8% versus DIA (Dow) +12.5%, SPY (S&P 500) +13.8%, QQQ (Nasdaq 100) +15.2% and IWM (Russell 2000) +12.0%.

Volume & Liquidity 4.39× 3-mo avg
Today 35,949 3-mo avg 8.2K
1W
1.6K
1M
4.4K
3M
8.2K
6M
17.4K
YTD
21.0K
1Y
20.5K

TVGN most recently traded 35,949 shares against a 3-month average daily volume of 8.2K.

More News

Read More
News headline image
Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements
September 30, 2026
From Tevogen Inc.
Via GlobeNewswire
News headline image
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Bio Announces 2026 Annual Meeting of Stockholders
July 13, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Announces Formation of a Healthcare Services Initiative
June 09, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
May 28, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
May 21, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Letter to Shareholders from CEO Dr. Ryan Saadi
May 18, 2026
From Tevogen Bio Inc
Via GlobeNewswire
What's going on in today's session ↗
May 14, 2026
Via Chartmill
News headline image
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
May 12, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal
April 27, 2026
From Tevogen Bio Inc
Via GlobeNewswire
What's going on in today's pre-market session ↗
April 24, 2026
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
April 21, 2026
Via Chartmill
News headline image
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
March 26, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement
March 25, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)
March 18, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
March 13, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure
March 13, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform
March 11, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
March 09, 2026
Via Benzinga
Topics Stocks
News headline image
Tevogen Names Leadership Team to Execute Diversified Growth Strategy
March 09, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen CEO Says ‘Actively Evaluating’ Potential Acquisitions ↗
March 06, 2026
Via Stocktwits
News headline image
Letter to Shareholders from CEO Dr. Ryan Saadi
March 06, 2026
From Tevogen Bio Inc
Via GlobeNewswire
News headline image
Tevogen Shares Take Further Beating On Gauging Deal With Apozel Pharmaceuticals ↗
March 05, 2026
Via Stocktwits

Frequently Asked Questions

Is Tevogen Inc. - Common Stock publicly traded?
Yes, Tevogen Inc. - Common Stock is publicly traded.
What exchange does Tevogen Inc. - Common Stock trade on?
Tevogen Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tevogen Inc. - Common Stock?
The ticker symbol for Tevogen Inc. - Common Stock is TVGN on the Nasdaq Stock Market
What is the current price of Tevogen Inc. - Common Stock?
The current price of Tevogen Inc. - Common Stock is 6.810
When was Tevogen Inc. - Common Stock last traded?
The last trade of Tevogen Inc. - Common Stock was at 10/22/26 03:47 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap